REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY
REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY
The report was published on 06 de novembro de 2026 às 04:20 by Amgen and is part of the World news coverage.
Quick answers
Who reported this story?
It was first reported by Amgen on 06 de novembro de 2026 às 04:20.
What is the category?
It is filed under World news on Rio Warzone News.
